Low-frequency Rotating Magnetic System Combined With Systemic Anti-tumor Therapy for Advanced Lung Cancer

• Status: Unknown status
• Trial end date: 2020-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether Low-frequency Rotating Magnetic Therapy System is effective and safe in the treatment of advanced lung cancer.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chinese PLA General Hospital
• Collaborators: Shandong Provincial Hospital; Shandong University of Traditional Chinese Medicine; Xijing Hospital

Criteria

Inclusion Criteria:

• Willing and able to give written informed consent

• Male or female aged 18 years and older

• Histologic diagnosis of non-small cell lung cancer (unable to receive surgery) or small cell lung cancer (limited stage or extensive stage)

• Eastern Cooperative Oncology Group (ECOG) performance status (PS) ≤ 3- going to receive systemic anti-tumor therapy

• Measurable disease based on RECIST 1.1

• Adequate hematologic and organ function

Exclusion Criteria:

• Currently participating and receiving study therapy in, or has participated in a study of an investigational agent and received study therapy or used an investigational device

• Unable to lie in bed

• With any metal implants in body

• Human immunodeficiency virus (HIV)

• Malignancies other than lung cancer within 5 years prior to randomization

• History or current evidence of any condition, therapy or laboratory abnormality that might confound the results of the trial or interfere with the subject's participation for the full duration of the trial

• Pregnant or breastfeeding, or expecting to conceive or father children within the projected duration of the trial